Change is going to be forced on big pharma

  • Republicans have indicated that they are willing to work with democrats on drug pricing initiatives.
  • Drug companies are focusing lobbying efforts to use a possible lame-duck session of Congress to peel back a legislative loss they suffered earlier this year.
  • Pharma is making a lobbying push to roll back seniors’ drug discounts at a time when they are reporting near record profits.
  • So far in 2018, PhRMA spent more than $20 million, according to the Center for Responsive Politics, and was the third-largest spender.

Continue reading

How to use content marketing for pharma

  • Content marketing when compared to paid search, gets three times the leads per dollar spent.
  • Web sites publishing 16-plus posts a month get almost 3.5 times more traffic than businesses publishing zero to four articles.
  • 60% of marketers create at least one piece of content each day.
  • Online health seekers are overwhelmed with the mount of online health content and 85% would prefer to get all their questions answered on ONE site.
    Continue reading

Today healthcare is on the ballot but pharma isn’t listening

  • 62 percent of cancer patients report being in debt due to their treatment.
    55 percent accrue at least $10,000 in debt, while 3 percent file for bankruptcy.
  • Almost 700,000 people in the U.S. declare bankruptcy due medical bills.
  • American’s are sick and tired of a healthcare system that costs too much and provides too little.

Continue reading

Pharma at war with Azar?

  • After reporting a 45% increase in quarterly profit Pfizer said “it’s business as normal”.
  • Drug companies have made clear that they’ll never voluntarily reduce prices.
  • The pharma industry has spent more than $216 million on lobbying this year.
  • “Telling companies to voluntarily lower their prices and expecting it to happen on a consistent basis is not a realistic long-term policy proposition,” said Anthony T. LoSasso, a professor of health policy and administration at the University of Illinois at Chicago.

Continue reading

Patients skeptical of new prescription drugs

  • Patients are skeptical of new prescription drugs.
  • In addition to going to a pharma site they do a LOT of online research.
  • Pharma sites are not meeting their needs when it comes the information they need to try or switch to new medications.
  • People are using social media to learn about new medications, but the trust of others posts remains low.

Continue reading